Literature DB >> 9092738

Uremic pruritus: roles of parathyroid hormone and substance P.

Y L Cho1, H N Liu, T P Huang, D C Tarng.   

Abstract

BACKGROUND: Most patients receiving maintenance hemodialysis have pruritus, but its underlying mechanism remains unknown. Secondary hyperparathyroidism is another common problem in these patients, but its role in uremic pruritus is controversial. Capsaicin can deplete substance P from the peripheral neurons and is known to be effective in the treatment of pain and itching.
OBJECTIVE: Our purpose was to evaluate the role of parathyroid hormone (PTH) and substance P in uremic pruritus and to elucidate the underlying mechanisms.
METHODS: The study contained two phases. In phase I, we analyzed the correlation between the intensity of itching and serum levels of intact PTH. In phase II, patients with moderate to severe pruritus were placed into two groups: one with high PTH levels and one with low levels. A double-blind, placebo-controlled study of capsaicin 0.025% cream was conducted in phase II.
RESULTS: Serum levels of intact PTH did not correlate with the intensity of pruritus and did not significantly change during treatment with capsaicin or placebo. Capsaicin was significantly more effective in alleviating uremic pruritus than the placebo, and no serious side effects were noted.
CONCLUSION: Uremic pruritus is not related to PTH. Substance P may act as a neurotransmitter in uremic pruritus and topical capsaicin can be used in the treatment of localized pruritus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092738     DOI: 10.1016/s0190-9622(97)70240-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  22 in total

1.  Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysis. A study of 458 patients.

Authors:  Abderrahmen Masmoudi; Mounira Hajjaji Darouiche; Haifa Ben Salah; Mohamed Ben Hmida; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2014-12-31

Review 2.  Pharmacological interventions for pruritus in adult palliative care patients.

Authors:  Waldemar Siemens; Carola Xander; Joerg J Meerpohl; Sabine Buroh; Gerd Antes; Guido Schwarzer; Gerhild Becker
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

Review 3.  Pruritus in Kidney Disease.

Authors:  Sara A Combs; J Pedro Teixeira; Michael J Germain
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

Review 4.  New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma.

Authors:  Hui Wang; Gil Yosipovitch
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

Review 5.  Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies.

Authors:  Ann Lonsdale-Eccles; Andrew J Carmichael
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Nitric oxide enhances substance P-induced itch-associated responses in mice.

Authors:  Tsugunobu Andoh; Yasushi Kuraishi
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 7.  Skin problems in chronic kidney disease.

Authors:  Dirk R J Kuypers
Journal:  Nat Clin Pract Nephrol       Date:  2009-02-03

8.  A prospective study of cutaneous abnormalities in patients with chronic kidney disease.

Authors:  E A Thomas; B Pawar; A Thomas
Journal:  Indian J Nephrol       Date:  2012-03

9.  Interventions for itch in people with advanced chronic kidney disease.

Authors:  Daniel Hercz; Simon H Jiang; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2020-12-07

10.  Efficacy of omega-3 fatty acids supplementation in treatment of uremic pruritus in hemodialysis patients: a double-blind randomized controlled trial.

Authors:  E Ghanei; J Zeinali; M Borghei; M Homayouni
Journal:  Iran Red Crescent Med J       Date:  2012-09-30       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.